Sort   by:  
 Page size 
UnknownEarly Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Not available
S-EPMC4879714 | biostudies-literature
UnknownRisk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
Not available
S-EPMC1895525 | biostudies-literature
UnknownEarly event status informs subsequent outcome in newly diagnosed follicular lymphoma.
Not available
S-EPMC5073042 | biostudies-literature
UnknownGenome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
Not available
S-EPMC4879713 | biostudies-literature
UnknownEvent-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.
Not available
S-EPMC3965261 | biostudies-literature
UnknownDisease, treatment, and outcome differences between men and women with follicular lymphoma in the United States.
Not available
S-EPMC5564298 | biostudies-literature
UnknownEvolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes.
Not available
S-EPMC8864651 | biostudies-literature
UnknownQuality of life at diagnosis predicts overall survival in patients with aggressive lymphoma.
Not available
S-EPMC6402794 | biostudies-literature
UnknownPersonalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.
Not available
S-EPMC4801345 | biostudies-literature
UnknownModeling historic environmental pollutant exposures and non-Hodgkin lymphoma risk.
Not available
S-EPMC10031495 | biostudies-literature
Sort   by:  
 Page size